Thalidomide treatment for refractory HIV-associated colitis: a case series.
Thalidomide has been used as a treatment for various human immunodeficiency virus (HIV)-associated and non-HIV-associated illnesses, generally in cases in which inflammatory disease is refractory to standard therapy. Here, we discuss the successful use of thalidomide in 3 patients with severe, idiopathic HIV-associated colitis.
Johnson
Leann
L
Department of Infectious Diseases and Tropical Medicine, North Manchester General Hospital, Manchester, United Kingdom. leann.johnson@pat.nhs.uk
Jarvis
Joseph N
JN
Wilkins
Edmund G L
EG
Hay
Phillip E
PE
D000328:Adult; D003092:Colitis / Q000188:drug therapy*; D003106:Colon / Q000473:pathology; D003113:Colonoscopy; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007413:Intestinal Mucosa / Q000473:pathology; D008297:Male; D008875:Middle Aged; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D013792:Thalidomide